BIOS Fund I, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 112,303 shares at $4.20 ($472K) on 2024-01-17, disclosed to the SEC on 2024-01-19.
Open-market sale of $472k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.20 | 5,475 | $23K | 4.9% |
| 2 | $4.20 | 12,521 | $53K | 11.1% |
| 3 | $4.20 | 12,521 | $53K | 11.1% |
| 4 | $4.20 | 40,893 | $172K | 36.4% |
| 5 | $4.20 | 40,893 | $172K | 36.4% |
| Total | $4.20 avg | 112,303 |
| $472K |
| 100% |
| Filing → |
| LTRN | SELL | 2022-11-09 | $2.5M | — | Filing → |